Psoralene in repigmentation of tuberculoid leprosy.

Printer-friendly version
TitlePsoralene in repigmentation of tuberculoid leprosy.
Publication TypeJournal Article
AuthorsAmar AK
Abbrev. JournalIndian J Dermatol
JournalIndian journal of dermatology
Year of Publication1989
Volume34
Issue1
Pagination9-12
Publication Languageeng
KeywordsFemale, Humans, Leprosy, Tuberculoid, Male, Pigmentation Disorders, PUVA Therapy, Sex Factors
Abstract

Photoactivated psoralens were studied in sixty cases of tuberculoid leprosy for the repigmentation of hypopigmented macules. It was observed that in 42 (70%) cases there was significant repigmentation within 6 months of therapy; in 5 (8.33%) cases there was mild to moderate repigmentation and in 13 (22.64%) cases, there was no change. No significant untoward effects of drug were encountered, except in four patients (6.66%), who developed, marked erythema and eczematous reaction.

PubMed URL

http://www.ncbi.nlm.nih.gov/pubmed/2625362?dopt=Abstract

More resources on: